| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, N-Methyl-D-Aspartate | 38 | 2023 | 269 | 16.050 |
Why?
|
| Neuralgia | 34 | 2023 | 258 | 13.060 |
Why?
|
| Posterior Horn Cells | 47 | 2023 | 129 | 11.600 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 36 | 2024 | 139 | 11.460 |
Why?
|
| Spinal Cord | 65 | 2023 | 726 | 10.770 |
Why?
|
| Rats, Sprague-Dawley | 145 | 2024 | 2252 | 8.520 |
Why?
|
| Sympathetic Nervous System | 30 | 2023 | 161 | 7.480 |
Why?
|
| Rats | 166 | 2024 | 6637 | 7.400 |
Why?
|
| Hypertension | 26 | 2023 | 1613 | 6.270 |
Why?
|
| Excitatory Postsynaptic Potentials | 46 | 2024 | 254 | 6.160 |
Why?
|
| Neurons | 47 | 2024 | 2465 | 6.030 |
Why?
|
| Neurons, Afferent | 35 | 2022 | 130 | 5.950 |
Why?
|
| Sensory Receptor Cells | 16 | 2023 | 151 | 5.880 |
Why?
|
| Hyperalgesia | 25 | 2023 | 244 | 5.350 |
Why?
|
| Ganglia, Spinal | 32 | 2022 | 251 | 5.060 |
Why?
|
| Synaptic Transmission | 27 | 2021 | 476 | 5.000 |
Why?
|
| gamma-Aminobutyric Acid | 29 | 2016 | 289 | 4.740 |
Why?
|
| Calcium Channels, L-Type | 7 | 2021 | 76 | 4.510 |
Why?
|
| Glutamic Acid | 25 | 2021 | 336 | 4.480 |
Why?
|
| Receptors, Opioid, mu | 16 | 2022 | 92 | 4.270 |
Why?
|
| Pain | 37 | 2022 | 1696 | 4.270 |
Why?
|
| Synapses | 24 | 2024 | 556 | 4.200 |
Why?
|
| Receptors, AMPA | 8 | 2024 | 83 | 4.010 |
Why?
|
| Morphine | 20 | 2023 | 332 | 3.950 |
Why?
|
| Hypothalamus | 12 | 2023 | 283 | 3.710 |
Why?
|
| Diabetic Neuropathies | 13 | 2019 | 101 | 3.630 |
Why?
|
| TRPV Cation Channels | 14 | 2019 | 74 | 3.510 |
Why?
|
| Analgesics, Opioid | 28 | 2023 | 1457 | 3.220 |
Why?
|
| Animals | 226 | 2024 | 62771 | 3.210 |
Why?
|
| Receptors, Muscarinic | 18 | 2016 | 73 | 3.200 |
Why?
|
| Presynaptic Terminals | 14 | 2020 | 121 | 3.160 |
Why?
|
| Nitric Oxide | 18 | 2017 | 665 | 2.890 |
Why?
|
| Receptors, Metabotropic Glutamate | 8 | 2020 | 65 | 2.750 |
Why?
|
| Nociceptors | 19 | 2019 | 97 | 2.710 |
Why?
|
| Rats, Inbred WKY | 22 | 2023 | 112 | 2.710 |
Why?
|
| Analgesics | 18 | 2023 | 408 | 2.700 |
Why?
|
| Calcium Channels | 10 | 2019 | 213 | 2.650 |
Why?
|
| Rats, Inbred SHR | 21 | 2023 | 113 | 2.640 |
Why?
|
| Receptors, Presynaptic | 8 | 2022 | 27 | 2.500 |
Why?
|
| Up-Regulation | 14 | 2022 | 2465 | 2.470 |
Why?
|
| Chronic Pain | 6 | 2023 | 262 | 2.470 |
Why?
|
| Nociception | 9 | 2022 | 47 | 2.390 |
Why?
|
| Calcineurin | 7 | 2024 | 131 | 2.380 |
Why?
|
| Patch-Clamp Techniques | 34 | 2020 | 404 | 2.300 |
Why?
|
| Protein Kinase C | 8 | 2022 | 419 | 2.290 |
Why?
|
| Neuronal Plasticity | 12 | 2022 | 326 | 2.250 |
Why?
|
| Receptors, GABA-B | 9 | 2010 | 34 | 2.200 |
Why?
|
| Calcineurin Inhibitors | 5 | 2024 | 68 | 2.180 |
Why?
|
| Casein Kinase II | 5 | 2014 | 60 | 2.140 |
Why?
|
| Afferent Pathways | 16 | 2009 | 67 | 2.130 |
Why?
|
| Spinal Nerves | 9 | 2017 | 45 | 2.110 |
Why?
|
| Peripheral Nerve Injuries | 7 | 2018 | 61 | 1.910 |
Why?
|
| Neural Inhibition | 16 | 2010 | 161 | 1.870 |
Why?
|
| Blood Pressure | 20 | 2023 | 1594 | 1.840 |
Why?
|
| Excitatory Amino Acid Antagonists | 17 | 2017 | 164 | 1.820 |
Why?
|
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 12 | 2022 | 33 | 1.790 |
Why?
|
| Male | 181 | 2024 | 128454 | 1.760 |
Why?
|
| Diabetes Mellitus, Experimental | 10 | 2011 | 240 | 1.750 |
Why?
|
| Tacrolimus | 5 | 2024 | 351 | 1.700 |
Why?
|
| Calcium Channels, T-Type | 5 | 2011 | 28 | 1.690 |
Why?
|
| Calcium Channels, N-Type | 5 | 2015 | 40 | 1.630 |
Why?
|
| Inhibitory Postsynaptic Potentials | 9 | 2010 | 48 | 1.620 |
Why?
|
| Receptor, Angiotensin, Type 1 | 3 | 2023 | 81 | 1.590 |
Why?
|
| Solute Carrier Family 12, Member 2 | 3 | 2023 | 13 | 1.520 |
Why?
|
| Angiotensin II | 5 | 2018 | 204 | 1.480 |
Why?
|
| Acute Pain | 3 | 2022 | 48 | 1.470 |
Why?
|
| Receptor, Muscarinic M2 | 9 | 2018 | 24 | 1.470 |
Why?
|
| Membrane Potentials | 16 | 2014 | 462 | 1.440 |
Why?
|
| In Vitro Techniques | 27 | 2014 | 1745 | 1.390 |
Why?
|
| Histone-Lysine N-Methyltransferase | 3 | 2020 | 462 | 1.390 |
Why?
|
| Pain Measurement | 19 | 2019 | 1018 | 1.340 |
Why?
|
| Pain Threshold | 17 | 2018 | 133 | 1.330 |
Why?
|
| Chlorides | 3 | 2016 | 141 | 1.330 |
Why?
|
| Diterpenes | 16 | 2021 | 117 | 1.280 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 7 | 2011 | 24 | 1.220 |
Why?
|
| Calcium | 11 | 2024 | 1598 | 1.210 |
Why?
|
| Glycine | 9 | 2014 | 319 | 1.200 |
Why?
|
| Bradykinin | 16 | 2007 | 89 | 1.200 |
Why?
|
| Medulla Oblongata | 6 | 2014 | 47 | 1.090 |
Why?
|
| Drug Tolerance | 4 | 2019 | 123 | 1.080 |
Why?
|
| Autonomic Nervous System | 3 | 2013 | 74 | 1.050 |
Why?
|
| Heart | 10 | 2007 | 1211 | 1.050 |
Why?
|
| Dose-Response Relationship, Drug | 31 | 2020 | 5108 | 1.040 |
Why?
|
| 4-Aminopyridine | 5 | 2014 | 43 | 1.040 |
Why?
|
| Long-Term Potentiation | 2 | 2021 | 181 | 1.020 |
Why?
|
| Receptor, Muscarinic M4 | 7 | 2011 | 21 | 1.000 |
Why?
|
| Clonidine | 9 | 2007 | 68 | 0.990 |
Why?
|
| Injections, Spinal | 23 | 2016 | 276 | 0.980 |
Why?
|
| Potassium Channel Blockers | 11 | 2014 | 114 | 0.970 |
Why?
|
| Adrenergic alpha-Agonists | 9 | 2008 | 41 | 0.960 |
Why?
|
| Mice, Knockout | 17 | 2022 | 5837 | 0.960 |
Why?
|
| Ion Channels | 3 | 2020 | 242 | 0.930 |
Why?
|
| Electrophysiology | 18 | 2014 | 367 | 0.930 |
Why?
|
| DNA Demethylation | 1 | 2023 | 11 | 0.930 |
Why?
|
| Vesicular Glutamate Transport Protein 2 | 3 | 2021 | 28 | 0.930 |
Why?
|
| Bicuculline | 13 | 2016 | 64 | 0.920 |
Why?
|
| Muscarinic Agonists | 11 | 2010 | 42 | 0.910 |
Why?
|
| Mice | 32 | 2023 | 35992 | 0.900 |
Why?
|
| Receptor, Cannabinoid, CB1 | 3 | 2020 | 36 | 0.900 |
Why?
|
| Drug Interactions | 15 | 2016 | 586 | 0.890 |
Why?
|
| Enkephalin, D-Penicillamine (2,5)- | 5 | 2008 | 16 | 0.880 |
Why?
|
| GABA Antagonists | 13 | 2010 | 60 | 0.880 |
Why?
|
| Amitriptyline | 1 | 2023 | 37 | 0.870 |
Why?
|
| Plant Lectins | 5 | 2008 | 28 | 0.870 |
Why?
|
| Receptor, Metabotropic Glutamate 5 | 4 | 2023 | 21 | 0.870 |
Why?
|
| Protein Subunits | 4 | 2021 | 282 | 0.860 |
Why?
|
| Acetylcholine | 6 | 2009 | 108 | 0.850 |
Why?
|
| Receptors, Glutamate | 3 | 2017 | 25 | 0.850 |
Why?
|
| Receptors, Cannabinoid | 1 | 2022 | 11 | 0.830 |
Why?
|
| Nociceptive Pain | 2 | 2019 | 9 | 0.810 |
Why?
|
| Streptozocin | 3 | 2019 | 72 | 0.810 |
Why?
|
| Homeostasis | 4 | 2016 | 960 | 0.810 |
Why?
|
| Nerve Fibers, Unmyelinated | 4 | 2007 | 15 | 0.810 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 11 | 2014 | 49 | 0.800 |
Why?
|
| Cannabinoids | 1 | 2022 | 43 | 0.800 |
Why?
|
| Theta Rhythm | 1 | 2021 | 30 | 0.790 |
Why?
|
| Potassium Channels | 2 | 2015 | 197 | 0.780 |
Why?
|
| Adrenergic Fibers | 2 | 2017 | 9 | 0.780 |
Why?
|
| Heart Rate | 7 | 2011 | 762 | 0.780 |
Why?
|
| Myocardial Ischemia | 8 | 2004 | 434 | 0.770 |
Why?
|
| Receptors, Drug | 4 | 2004 | 63 | 0.760 |
Why?
|
| Capsaicin | 8 | 2009 | 48 | 0.750 |
Why?
|
| Analgesia | 4 | 2019 | 98 | 0.750 |
Why?
|
| Protein Transport | 2 | 2021 | 738 | 0.730 |
Why?
|
| Electric Stimulation | 14 | 2014 | 491 | 0.720 |
Why?
|
| Gene-Environment Interaction | 1 | 2021 | 148 | 0.720 |
Why?
|
| Narcotics | 3 | 2006 | 128 | 0.720 |
Why?
|
| Cyclohexanecarboxylic Acids | 5 | 2009 | 43 | 0.720 |
Why?
|
| Muscarine | 4 | 2018 | 17 | 0.710 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2012 | 171 | 0.700 |
Why?
|
| Amines | 5 | 2009 | 86 | 0.700 |
Why?
|
| Peripheral Nervous System Diseases | 4 | 2009 | 408 | 0.700 |
Why?
|
| Reflex | 7 | 2004 | 70 | 0.680 |
Why?
|
| Pressoreceptors | 3 | 2009 | 22 | 0.670 |
Why?
|
| TRPA1 Cation Channel | 1 | 2019 | 9 | 0.670 |
Why?
|
| N-Methylaspartate | 2 | 2022 | 54 | 0.670 |
Why?
|
| Spinal Cord Dorsal Horn | 3 | 2023 | 12 | 0.660 |
Why?
|
| Receptors, GABA-A | 3 | 2008 | 84 | 0.660 |
Why?
|
| Behavior, Animal | 13 | 2020 | 758 | 0.660 |
Why?
|
| Action Potentials | 12 | 2014 | 597 | 0.660 |
Why?
|
| Receptors, Opioid, delta | 4 | 2008 | 29 | 0.650 |
Why?
|
| Electrophysiological Phenomena | 5 | 2019 | 87 | 0.650 |
Why?
|
| Vasomotor System | 2 | 2010 | 32 | 0.640 |
Why?
|
| Mice, Inbred C57BL | 11 | 2021 | 7216 | 0.640 |
Why?
|
| Organ Culture Techniques | 6 | 2020 | 250 | 0.640 |
Why?
|
| Ischemia | 9 | 1997 | 403 | 0.630 |
Why?
|
| HEK293 Cells | 7 | 2021 | 1473 | 0.630 |
Why?
|
| Spinal Nerve Roots | 4 | 2014 | 69 | 0.620 |
Why?
|
| Disease Models, Animal | 20 | 2018 | 7461 | 0.620 |
Why?
|
| Physical Stimulation | 10 | 2014 | 120 | 0.610 |
Why?
|
| Norepinephrine | 8 | 2023 | 284 | 0.610 |
Why?
|
| Gene Expression | 3 | 2013 | 3681 | 0.600 |
Why?
|
| Neural Pathways | 8 | 2008 | 316 | 0.600 |
Why?
|
| Potassium Channels, Voltage-Gated | 2 | 2010 | 70 | 0.590 |
Why?
|
| Receptors, Nicotinic | 5 | 2001 | 179 | 0.590 |
Why?
|
| Renin-Angiotensin System | 1 | 2018 | 111 | 0.590 |
Why?
|
| Hippocampus | 3 | 2020 | 976 | 0.590 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 2 | 2008 | 39 | 0.580 |
Why?
|
| Receptor, Cannabinoid, CB2 | 5 | 2020 | 19 | 0.570 |
Why?
|
| Kv1.2 Potassium Channel | 2 | 2007 | 17 | 0.560 |
Why?
|
| Gene Silencing | 2 | 2020 | 834 | 0.560 |
Why?
|
| Microinjections | 6 | 2020 | 108 | 0.560 |
Why?
|
| Kv1.1 Potassium Channel | 2 | 2007 | 42 | 0.550 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 2 | 2018 | 36 | 0.550 |
Why?
|
| Casein Kinase I | 2 | 2015 | 23 | 0.550 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2017 | 184 | 0.540 |
Why?
|
| Vestibular Nuclei | 1 | 2016 | 15 | 0.540 |
Why?
|
| Receptors, Opioid | 3 | 2022 | 40 | 0.540 |
Why?
|
| Nerve Fibers | 7 | 2009 | 122 | 0.540 |
Why?
|
| Cats | 20 | 2002 | 174 | 0.530 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2017 | 132 | 0.520 |
Why?
|
| Symporters | 2 | 2016 | 101 | 0.520 |
Why?
|
| Signal Transduction | 8 | 2014 | 12206 | 0.520 |
Why?
|
| Brain Ischemia | 1 | 2018 | 316 | 0.520 |
Why?
|
| Hot Temperature | 6 | 2017 | 289 | 0.520 |
Why?
|
| Calpain | 2 | 2013 | 72 | 0.520 |
Why?
|
| Paclitaxel | 3 | 2023 | 2099 | 0.510 |
Why?
|
| Bortezomib | 1 | 2017 | 553 | 0.510 |
Why?
|
| Penicillamine | 4 | 2004 | 21 | 0.500 |
Why?
|
| Connexins | 1 | 2015 | 77 | 0.490 |
Why?
|
| Viscera | 5 | 2001 | 92 | 0.490 |
Why?
|
| Baroreflex | 2 | 2009 | 11 | 0.490 |
Why?
|
| Neostigmine | 5 | 2004 | 18 | 0.490 |
Why?
|
| Locus Coeruleus | 3 | 2004 | 33 | 0.490 |
Why?
|
| Epigenesis, Genetic | 3 | 2022 | 1432 | 0.490 |
Why?
|
| Adenosine | 4 | 2010 | 300 | 0.490 |
Why?
|
| Sciatic Nerve | 6 | 2021 | 123 | 0.480 |
Why?
|
| Peptides | 7 | 2022 | 1529 | 0.480 |
Why?
|
| Potassium Channels, Calcium-Activated | 1 | 2014 | 17 | 0.480 |
Why?
|
| Receptor, Muscarinic M3 | 4 | 2009 | 21 | 0.480 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 887 | 0.470 |
Why?
|
| Amygdala | 2 | 2005 | 120 | 0.470 |
Why?
|
| Trauma, Nervous System | 1 | 2013 | 12 | 0.460 |
Why?
|
| src-Family Kinases | 1 | 2016 | 487 | 0.450 |
Why?
|
| Calmodulin | 2 | 2014 | 264 | 0.450 |
Why?
|
| Down-Regulation | 5 | 2018 | 2109 | 0.450 |
Why?
|
| Cholinergic Agents | 4 | 2016 | 21 | 0.450 |
Why?
|
| Neuromuscular Junction | 2 | 2014 | 107 | 0.440 |
Why?
|
| Pons | 1 | 2013 | 50 | 0.440 |
Why?
|
| Membrane Proteins | 3 | 2020 | 2953 | 0.430 |
Why?
|
| Glutamates | 2 | 2020 | 134 | 0.420 |
Why?
|
| Sodium-Potassium-Chloride Symporters | 1 | 2012 | 13 | 0.420 |
Why?
|
| Tetrodotoxin | 4 | 2014 | 73 | 0.420 |
Why?
|
| NFATC Transcription Factors | 1 | 2013 | 98 | 0.420 |
Why?
|
| Anticonvulsants | 3 | 2001 | 469 | 0.410 |
Why?
|
| Brain Injuries | 1 | 2018 | 800 | 0.410 |
Why?
|
| Anesthetics, Local | 3 | 2004 | 175 | 0.400 |
Why?
|
| Sciatic Neuropathy | 2 | 2002 | 12 | 0.400 |
Why?
|
| Supraoptic Nucleus | 2 | 2001 | 9 | 0.400 |
Why?
|
| Cerebellum | 1 | 2016 | 476 | 0.400 |
Why?
|
| Oxotremorine | 9 | 2014 | 24 | 0.400 |
Why?
|
| S-Nitroso-N-Acetylpenicillamine | 4 | 2017 | 16 | 0.400 |
Why?
|
| Blotting, Western | 7 | 2016 | 3648 | 0.400 |
Why?
|
| Protein Binding | 7 | 2021 | 3536 | 0.390 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2012 | 71 | 0.390 |
Why?
|
| Lectins | 5 | 2010 | 157 | 0.390 |
Why?
|
| GABA Agonists | 5 | 2009 | 27 | 0.380 |
Why?
|
| Interneurons | 3 | 2007 | 152 | 0.380 |
Why?
|
| Calcium Channel Blockers | 5 | 2009 | 145 | 0.380 |
Why?
|
| Oligopeptides | 4 | 2008 | 452 | 0.370 |
Why?
|
| Nitric Oxide Donors | 5 | 2007 | 51 | 0.370 |
Why?
|
| Cholinesterase Inhibitors | 3 | 2004 | 116 | 0.370 |
Why?
|
| Baclofen | 5 | 2009 | 58 | 0.370 |
Why?
|
| Female | 43 | 2023 | 148509 | 0.370 |
Why?
|
| Acetates | 3 | 2000 | 122 | 0.370 |
Why?
|
| Pirenzepine | 2 | 2016 | 10 | 0.360 |
Why?
|
| Repressor Proteins | 1 | 2018 | 1726 | 0.360 |
Why?
|
| RNA, Small Interfering | 4 | 2014 | 2214 | 0.360 |
Why?
|
| Somatostatin | 3 | 2006 | 120 | 0.360 |
Why?
|
| GTP-Binding Proteins | 4 | 2008 | 346 | 0.350 |
Why?
|
| KATP Channels | 1 | 2010 | 12 | 0.350 |
Why?
|
| Naltrexone | 3 | 2008 | 99 | 0.350 |
Why?
|
| Muscarinic Antagonists | 9 | 2006 | 82 | 0.350 |
Why?
|
| Glycine Agents | 2 | 2008 | 16 | 0.350 |
Why?
|
| Stroke | 1 | 2018 | 1093 | 0.350 |
Why?
|
| Touch | 4 | 2017 | 70 | 0.350 |
Why?
|
| Yohimbine | 4 | 2023 | 32 | 0.340 |
Why?
|
| Electroacupuncture | 5 | 2013 | 34 | 0.340 |
Why?
|
| Antineoplastic Agents | 3 | 2023 | 14679 | 0.340 |
Why?
|
| Infarction, Middle Cerebral Artery | 2 | 2020 | 43 | 0.340 |
Why?
|
| RNA, Messenger | 6 | 2023 | 6483 | 0.340 |
Why?
|
| Ion Channel Gating | 5 | 2011 | 153 | 0.340 |
Why?
|
| Aminobutyrates | 2 | 2008 | 15 | 0.320 |
Why?
|
| Cells, Cultured | 6 | 2020 | 5782 | 0.320 |
Why?
|
| Synaptophysin | 5 | 2007 | 84 | 0.320 |
Why?
|
| Neuroprotective Agents | 2 | 2018 | 219 | 0.310 |
Why?
|
| Neuralgia, Postherpetic | 2 | 2021 | 8 | 0.310 |
Why?
|
| Histones | 3 | 2022 | 1510 | 0.310 |
Why?
|
| Digestive System | 3 | 1997 | 121 | 0.300 |
Why?
|
| Cardiovascular Physiological Phenomena | 3 | 2001 | 46 | 0.300 |
Why?
|
| Nitric Oxide Synthase Type I | 4 | 2017 | 56 | 0.300 |
Why?
|
| Reaction Time | 6 | 2006 | 243 | 0.300 |
Why?
|
| Inflammation | 6 | 2022 | 2527 | 0.300 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 3416 | 0.300 |
Why?
|
| Cyclic GMP | 3 | 2017 | 124 | 0.290 |
Why?
|
| Nerve Tissue Proteins | 1 | 2015 | 1574 | 0.290 |
Why?
|
| Tissue Culture Techniques | 2 | 2017 | 112 | 0.290 |
Why?
|
| Enzyme Inhibitors | 9 | 2008 | 1985 | 0.290 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2007 | 487 | 0.290 |
Why?
|
| Gene Expression Regulation | 7 | 2016 | 4182 | 0.280 |
Why?
|
| Drug Delivery Systems | 1 | 2011 | 662 | 0.280 |
Why?
|
| Promoter Regions, Genetic | 3 | 2020 | 3245 | 0.270 |
Why?
|
| Benzodiazepines | 2 | 2011 | 181 | 0.270 |
Why?
|
| Isoenzymes | 2 | 2017 | 663 | 0.270 |
Why?
|
| Receptors, GABA | 1 | 2005 | 22 | 0.260 |
Why?
|
| Receptors, Purinergic P1 | 3 | 2003 | 29 | 0.260 |
Why?
|
| Guanosine Diphosphate | 3 | 2010 | 28 | 0.260 |
Why?
|
| Nerve Fibers, Myelinated | 3 | 2003 | 121 | 0.260 |
Why?
|
| Thionucleotides | 3 | 2010 | 67 | 0.250 |
Why?
|
| Parasympathetic Nervous System | 1 | 2005 | 26 | 0.250 |
Why?
|
| Biophysics | 3 | 2010 | 116 | 0.250 |
Why?
|
| Periaqueductal Gray | 1 | 2004 | 12 | 0.250 |
Why?
|
| Calcium Channels, Q-Type | 1 | 2004 | 10 | 0.240 |
Why?
|
| Calcium Channels, P-Type | 1 | 2004 | 11 | 0.240 |
Why?
|
| Egtazic Acid | 4 | 2010 | 60 | 0.240 |
Why?
|
| Nitric Oxide Synthase | 6 | 2003 | 330 | 0.240 |
Why?
|
| Analysis of Variance | 6 | 2014 | 2314 | 0.240 |
Why?
|
| Angina Pectoris | 1 | 2004 | 68 | 0.240 |
Why?
|
| Substantia Gelatinosa | 1 | 2004 | 3 | 0.240 |
Why?
|
| Miniature Postsynaptic Potentials | 2 | 2014 | 8 | 0.230 |
Why?
|
| Phosphinic Acids | 3 | 2008 | 5 | 0.230 |
Why?
|
| Sodium Channels | 1 | 2004 | 115 | 0.230 |
Why?
|
| S-Nitrosothiols | 2 | 2000 | 7 | 0.220 |
Why?
|
| Splanchnic Nerves | 3 | 2001 | 14 | 0.220 |
Why?
|
| Pericardium | 1 | 2004 | 148 | 0.220 |
Why?
|
| Ethylmaleimide | 2 | 2017 | 18 | 0.220 |
Why?
|
| Abdomen | 5 | 1997 | 348 | 0.220 |
Why?
|
| Duloxetine Hydrochloride | 1 | 2023 | 17 | 0.220 |
Why?
|
| Receptors, Glycine | 2 | 2014 | 22 | 0.220 |
Why?
|
| Fentanyl | 2 | 2019 | 153 | 0.220 |
Why?
|
| Chelating Agents | 3 | 2010 | 130 | 0.220 |
Why?
|
| Aspartic Acid | 1 | 2023 | 136 | 0.220 |
Why?
|
| Receptors, Adrenergic | 1 | 2023 | 54 | 0.220 |
Why?
|
| Dichlororibofuranosylbenzimidazole | 2 | 2014 | 13 | 0.220 |
Why?
|
| Gallbladder | 4 | 2001 | 70 | 0.220 |
Why?
|
| Muscimol | 3 | 2008 | 17 | 0.220 |
Why?
|
| Fluorescent Antibody Technique | 5 | 2010 | 1153 | 0.220 |
Why?
|
| Histone Deacetylase 2 | 1 | 2022 | 36 | 0.210 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2022 | 8 | 0.210 |
Why?
|
| Adrenergic alpha-Antagonists | 5 | 2008 | 75 | 0.210 |
Why?
|
| Immunohistochemistry | 8 | 2006 | 7813 | 0.210 |
Why?
|
| Nucleus Accumbens | 1 | 2022 | 63 | 0.210 |
Why?
|
| Atropine | 5 | 2005 | 44 | 0.210 |
Why?
|
| Spinothalamic Tracts | 1 | 2002 | 19 | 0.210 |
Why?
|
| Soluble Guanylyl Cyclase | 2 | 2017 | 15 | 0.210 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 3 | 2009 | 43 | 0.210 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 2002 | 19 | 0.210 |
Why?
|
| Ganglionectomy | 2 | 2012 | 4 | 0.200 |
Why?
|
| Valine | 3 | 2014 | 184 | 0.200 |
Why?
|
| Cysteine | 2 | 2000 | 215 | 0.200 |
Why?
|
| Mice, Transgenic | 4 | 2018 | 4371 | 0.200 |
Why?
|
| Tritium | 3 | 2008 | 268 | 0.200 |
Why?
|
| Solitary Nucleus | 1 | 2001 | 8 | 0.200 |
Why?
|
| Organophosphorus Compounds | 1 | 2002 | 94 | 0.200 |
Why?
|
| Carbazoles | 2 | 2013 | 92 | 0.200 |
Why?
|
| Receptors, Bradykinin | 3 | 1998 | 6 | 0.190 |
Why?
|
| Blood Circulation | 1 | 2001 | 33 | 0.190 |
Why?
|
| Nerve Net | 1 | 2004 | 271 | 0.190 |
Why?
|
| Histone Code | 1 | 2022 | 86 | 0.190 |
Why?
|
| Gene Products, tat | 1 | 2021 | 65 | 0.190 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 2 | 2014 | 56 | 0.190 |
Why?
|
| Memantine | 2 | 2013 | 50 | 0.190 |
Why?
|
| Cell Membrane Permeability | 1 | 2021 | 126 | 0.190 |
Why?
|
| Neurotoxins | 1 | 2021 | 69 | 0.190 |
Why?
|
| KCNQ Potassium Channels | 2 | 2014 | 11 | 0.180 |
Why?
|
| Skin | 3 | 2011 | 1290 | 0.180 |
Why?
|
| Nestin | 1 | 2020 | 42 | 0.180 |
Why?
|
| Injections, Intravenous | 5 | 2005 | 596 | 0.180 |
Why?
|
| Ligation | 4 | 2009 | 207 | 0.180 |
Why?
|
| Brain | 2 | 2023 | 4257 | 0.180 |
Why?
|
| Ischemic Preconditioning | 1 | 2000 | 21 | 0.180 |
Why?
|
| Narcotic Antagonists | 3 | 2008 | 154 | 0.180 |
Why?
|
| Propionates | 1 | 2020 | 79 | 0.180 |
Why?
|
| Heart Conduction System | 3 | 1996 | 161 | 0.180 |
Why?
|
| Mercaptoethanol | 1 | 2000 | 16 | 0.180 |
Why?
|
| Antidepressive Agents | 1 | 2023 | 336 | 0.180 |
Why?
|
| Nerve Tissue | 1 | 2020 | 10 | 0.180 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2013 | 1212 | 0.180 |
Why?
|
| Membrane Transport Proteins | 1 | 2001 | 243 | 0.170 |
Why?
|
| Humans | 23 | 2022 | 270947 | 0.170 |
Why?
|
| Cell Membrane | 2 | 2014 | 907 | 0.170 |
Why?
|
| Hypoxia | 2 | 2020 | 467 | 0.170 |
Why?
|
| Brain Stem | 3 | 2014 | 185 | 0.170 |
Why?
|
| Endoplasmic Reticulum | 1 | 2021 | 335 | 0.170 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2020 | 77 | 0.170 |
Why?
|
| Phosphorylation | 2 | 2021 | 4985 | 0.160 |
Why?
|
| Permeability | 1 | 2019 | 161 | 0.160 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2000 | 230 | 0.160 |
Why?
|
| omega-Conotoxin GVIA | 2 | 2009 | 10 | 0.160 |
Why?
|
| Tetrazolium Salts | 1 | 2018 | 53 | 0.160 |
Why?
|
| Pyridazines | 2 | 2016 | 319 | 0.160 |
Why?
|
| Biophysical Phenomena | 2 | 2008 | 117 | 0.160 |
Why?
|
| Flagella | 1 | 2018 | 37 | 0.160 |
Why?
|
| Microscopy, Confocal | 4 | 2010 | 672 | 0.160 |
Why?
|
| Propanolamines | 2 | 2008 | 49 | 0.160 |
Why?
|
| Versicans | 2 | 2008 | 29 | 0.160 |
Why?
|
| Alkenes | 2 | 2016 | 12 | 0.160 |
Why?
|
| Arginine | 2 | 2017 | 509 | 0.160 |
Why?
|
| Nicotinic Antagonists | 4 | 2001 | 19 | 0.160 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 2 | 2011 | 23 | 0.160 |
Why?
|
| Time Factors | 8 | 2013 | 13112 | 0.150 |
Why?
|
| Methylation | 1 | 2020 | 626 | 0.150 |
Why?
|
| Chest Pain | 1 | 1999 | 171 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2014 | 3655 | 0.150 |
Why?
|
| Benzoates | 2 | 2014 | 130 | 0.150 |
Why?
|
| Guanylate Cyclase | 2 | 2011 | 77 | 0.150 |
Why?
|
| Piperidines | 5 | 2016 | 1089 | 0.150 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 272 | 0.150 |
Why?
|
| Lysine | 1 | 2020 | 428 | 0.150 |
Why?
|
| Central Nervous System Agents | 1 | 2017 | 20 | 0.150 |
Why?
|
| Triazoles | 2 | 2014 | 632 | 0.150 |
Why?
|
| Neuropeptide Y | 1 | 2017 | 50 | 0.150 |
Why?
|
| Receptors, Ghrelin | 1 | 2017 | 35 | 0.150 |
Why?
|
| Bupivacaine | 1 | 1998 | 74 | 0.150 |
Why?
|
| Ghrelin | 1 | 2017 | 78 | 0.140 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2021 | 5438 | 0.140 |
Why?
|
| Naloxone | 2 | 2008 | 109 | 0.140 |
Why?
|
| Xanthines | 2 | 2010 | 31 | 0.140 |
Why?
|
| Leukotriene B4 | 2 | 1995 | 21 | 0.140 |
Why?
|
| GABA-A Receptor Antagonists | 1 | 2016 | 15 | 0.140 |
Why?
|
| Protons | 1 | 1999 | 483 | 0.140 |
Why?
|
| Synaptosomes | 3 | 2000 | 40 | 0.130 |
Why?
|
| Kynurenic Acid | 2 | 2007 | 26 | 0.130 |
Why?
|
| Kidney | 4 | 2009 | 2261 | 0.130 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2019 | 744 | 0.130 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2016 | 90 | 0.130 |
Why?
|
| Dose-Response Relationship, Radiation | 2 | 2008 | 749 | 0.130 |
Why?
|
| DNA | 1 | 2023 | 3074 | 0.130 |
Why?
|
| Infertility, Male | 1 | 2018 | 310 | 0.130 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 1995 | 30 | 0.120 |
Why?
|
| 2-Amino-5-phosphonovalerate | 2 | 2007 | 27 | 0.120 |
Why?
|
| Gene Deletion | 1 | 2020 | 1482 | 0.120 |
Why?
|
| Transduction, Genetic | 1 | 2016 | 496 | 0.120 |
Why?
|
| Amino Acid Motifs | 1 | 2015 | 414 | 0.120 |
Why?
|
| Tubulin Modulators | 1 | 2014 | 65 | 0.120 |
Why?
|
| Glycoproteins | 2 | 2008 | 796 | 0.120 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2015 | 644 | 0.120 |
Why?
|
| Glyburide | 2 | 2014 | 30 | 0.120 |
Why?
|
| Death, Sudden | 1 | 2014 | 58 | 0.120 |
Why?
|
| Glucose | 1 | 2020 | 1249 | 0.120 |
Why?
|
| Sodium Channel Blockers | 2 | 2014 | 37 | 0.120 |
Why?
|
| Stress, Psychological | 1 | 2021 | 1043 | 0.120 |
Why?
|
| Endosomes | 1 | 2014 | 107 | 0.120 |
Why?
|
| Physical Exertion | 1 | 1993 | 114 | 0.110 |
Why?
|
| Dopamine beta-Hydroxylase | 2 | 2004 | 37 | 0.110 |
Why?
|
| Coronary Vessels | 5 | 2001 | 643 | 0.110 |
Why?
|
| Rotarod Performance Test | 1 | 2013 | 25 | 0.110 |
Why?
|
| Hemodynamics | 4 | 2001 | 971 | 0.110 |
Why?
|
| Cysteine Endopeptidases | 1 | 2014 | 266 | 0.110 |
Why?
|
| Microtubules | 1 | 2014 | 330 | 0.110 |
Why?
|
| Mechanoreceptors | 2 | 2005 | 29 | 0.110 |
Why?
|
| Keratinocytes | 2 | 2011 | 247 | 0.110 |
Why?
|
| Cyclopropanes | 1 | 2013 | 89 | 0.110 |
Why?
|
| Peptide Fragments | 3 | 2006 | 1329 | 0.110 |
Why?
|
| Ganglia, Sympathetic | 1 | 2012 | 34 | 0.100 |
Why?
|
| Synaptic Potentials | 1 | 2012 | 16 | 0.100 |
Why?
|
| Pyridines | 2 | 2014 | 1311 | 0.100 |
Why?
|
| beta-Endorphin | 1 | 2011 | 43 | 0.100 |
Why?
|
| Glycosylation | 1 | 2012 | 231 | 0.100 |
Why?
|
| Mecamylamine | 2 | 2001 | 16 | 0.100 |
Why?
|
| Nitrosation | 1 | 2011 | 9 | 0.100 |
Why?
|
| Radioligand Assay | 2 | 2009 | 57 | 0.100 |
Why?
|
| Cannabidiol | 1 | 2012 | 43 | 0.100 |
Why?
|
| Stress, Mechanical | 2 | 2003 | 275 | 0.100 |
Why?
|
| Temperature | 1 | 2013 | 541 | 0.100 |
Why?
|
| Injections, Intraventricular | 1 | 2011 | 126 | 0.100 |
Why?
|
| Intracellular Space | 2 | 2011 | 78 | 0.100 |
Why?
|
| Adaptation, Physiological | 1 | 2013 | 350 | 0.100 |
Why?
|
| Circadian Clocks | 1 | 2011 | 60 | 0.090 |
Why?
|
| Biological Transport | 1 | 2012 | 647 | 0.090 |
Why?
|
| Indole Alkaloids | 1 | 2010 | 8 | 0.090 |
Why?
|
| Nickel | 2 | 2008 | 45 | 0.090 |
Why?
|
| Nitroso Compounds | 2 | 2000 | 18 | 0.090 |
Why?
|
| Dizocilpine Maleate | 1 | 2010 | 26 | 0.090 |
Why?
|
| Receptor, trkB | 1 | 2010 | 53 | 0.090 |
Why?
|
| Tolbutamide | 1 | 2010 | 9 | 0.090 |
Why?
|
| Pertussis Toxin | 2 | 2007 | 64 | 0.090 |
Why?
|
| Receptor, Adenosine A1 | 1 | 2010 | 6 | 0.090 |
Why?
|
| High-Throughput Screening Assays | 1 | 2011 | 207 | 0.090 |
Why?
|
| Deferoxamine | 3 | 2007 | 29 | 0.090 |
Why?
|
| Nodose Ganglion | 1 | 2009 | 7 | 0.090 |
Why?
|
| Phenotype | 1 | 2021 | 6465 | 0.090 |
Why?
|
| Chromones | 1 | 2009 | 121 | 0.090 |
Why?
|
| Cell Line | 3 | 2012 | 5437 | 0.080 |
Why?
|
| Prefrontal Cortex | 1 | 2011 | 215 | 0.080 |
Why?
|
| Arachidonic Acids | 1 | 2009 | 34 | 0.080 |
Why?
|
| Polyunsaturated Alkamides | 1 | 2009 | 45 | 0.080 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2009 | 29 | 0.080 |
Why?
|
| Mibefradil | 1 | 2008 | 3 | 0.080 |
Why?
|
| Stimulation, Chemical | 2 | 2002 | 112 | 0.080 |
Why?
|
| Picrotoxin | 1 | 2008 | 21 | 0.080 |
Why?
|
| Dioxanes | 1 | 2008 | 11 | 0.080 |
Why?
|
| Strychnine | 1 | 2008 | 10 | 0.080 |
Why?
|
| Cyclopentanes | 1 | 2009 | 44 | 0.080 |
Why?
|
| Amiloride | 1 | 2008 | 50 | 0.080 |
Why?
|
| Triazines | 1 | 2010 | 123 | 0.080 |
Why?
|
| Anthracenes | 1 | 2008 | 48 | 0.080 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2008 | 31 | 0.080 |
Why?
|
| Phenylephrine | 1 | 2008 | 53 | 0.080 |
Why?
|
| Lactic Acid | 2 | 2002 | 312 | 0.080 |
Why?
|
| Chitosan | 1 | 2009 | 85 | 0.080 |
Why?
|
| Catecholamines | 1 | 1989 | 99 | 0.080 |
Why?
|
| Peripheral Nerves | 2 | 2000 | 162 | 0.080 |
Why?
|
| Cadmium | 1 | 2008 | 48 | 0.080 |
Why?
|
| Indomethacin | 3 | 2000 | 114 | 0.080 |
Why?
|
| Motor Activity | 1 | 2013 | 718 | 0.080 |
Why?
|
| Hypokalemia | 1 | 1989 | 61 | 0.080 |
Why?
|
| Pain Management | 2 | 2009 | 717 | 0.080 |
Why?
|
| Rhizotomy | 1 | 2008 | 23 | 0.080 |
Why?
|
| Vasoconstrictor Agents | 1 | 2009 | 166 | 0.080 |
Why?
|
| Biocompatible Materials | 1 | 2009 | 198 | 0.080 |
Why?
|
| Myasthenia Gravis | 1 | 2009 | 109 | 0.080 |
Why?
|
| Seizures | 1 | 2014 | 1048 | 0.080 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2008 | 34 | 0.080 |
Why?
|
| Splanchnic Circulation | 2 | 2001 | 58 | 0.080 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 4644 | 0.080 |
Why?
|
| Vasodilator Agents | 1 | 2009 | 238 | 0.080 |
Why?
|
| Benzimidazoles | 1 | 2011 | 441 | 0.080 |
Why?
|
| Cyclic ADP-Ribose | 1 | 2007 | 4 | 0.080 |
Why?
|
| Myocardial Infarction | 3 | 1995 | 1303 | 0.080 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 2007 | 27 | 0.070 |
Why?
|
| Flavanones | 1 | 2007 | 11 | 0.070 |
Why?
|
| Arachidonate 12-Lipoxygenase | 1 | 2007 | 18 | 0.070 |
Why?
|
| Thapsigargin | 1 | 2007 | 43 | 0.070 |
Why?
|
| Eating | 2 | 2017 | 449 | 0.070 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2007 | 188 | 0.070 |
Why?
|
| Myocardium | 3 | 2003 | 1249 | 0.070 |
Why?
|
| Metalloporphyrins | 1 | 2007 | 31 | 0.070 |
Why?
|
| Laminectomy | 1 | 2007 | 52 | 0.070 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 6789 | 0.070 |
Why?
|
| Extracellular Space | 1 | 2007 | 148 | 0.070 |
Why?
|
| Bradykinin Receptor Antagonists | 3 | 1998 | 3 | 0.070 |
Why?
|
| GABA Modulators | 1 | 2006 | 16 | 0.070 |
Why?
|
| Diazepam | 1 | 2006 | 46 | 0.070 |
Why?
|
| Cadmium Chloride | 1 | 2006 | 5 | 0.070 |
Why?
|
| Staining and Labeling | 1 | 2008 | 465 | 0.070 |
Why?
|
| Sulfur Radioisotopes | 2 | 2003 | 29 | 0.070 |
Why?
|
| Aryldialkylphosphatase | 1 | 2006 | 11 | 0.070 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2014 | 1836 | 0.070 |
Why?
|
| Benzylamines | 1 | 2006 | 101 | 0.070 |
Why?
|
| Sulfur Isotopes | 1 | 2006 | 4 | 0.070 |
Why?
|
| Glycine Plasma Membrane Transport Proteins | 1 | 2006 | 7 | 0.070 |
Why?
|
| Spinal Cord Injuries | 1 | 2009 | 349 | 0.070 |
Why?
|
| Glutamine | 1 | 2008 | 329 | 0.070 |
Why?
|
| Elapid Venoms | 1 | 2005 | 11 | 0.070 |
Why?
|
| Animals, Newborn | 2 | 2014 | 1397 | 0.070 |
Why?
|
| Scorpion Venoms | 1 | 2005 | 17 | 0.070 |
Why?
|
| Multiple Sclerosis | 1 | 2009 | 374 | 0.070 |
Why?
|
| Adrenergic Antagonists | 1 | 2005 | 19 | 0.070 |
Why?
|
| Limbic System | 1 | 2005 | 36 | 0.070 |
Why?
|
| Microdialysis | 3 | 2000 | 70 | 0.070 |
Why?
|
| Adrenergic alpha-1 Receptor Antagonists | 1 | 2005 | 27 | 0.070 |
Why?
|
| Portal Vein | 2 | 2001 | 364 | 0.070 |
Why?
|
| Nerve Degeneration | 1 | 2007 | 163 | 0.060 |
Why?
|
| Imidazoles | 2 | 2003 | 1059 | 0.060 |
Why?
|
| Tetraethylammonium | 1 | 2005 | 16 | 0.060 |
Why?
|
| KCNQ1 Potassium Channel | 1 | 2005 | 18 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 475 | 0.060 |
Why?
|
| Ruthenium Red | 1 | 2004 | 8 | 0.060 |
Why?
|
| Base Sequence | 1 | 2011 | 5496 | 0.060 |
Why?
|
| Administration, Topical | 1 | 2005 | 264 | 0.060 |
Why?
|
| Protein Phosphatase 1 | 1 | 2005 | 79 | 0.060 |
Why?
|
| DNA Methylation | 1 | 2015 | 2736 | 0.060 |
Why?
|
| Ferrets | 1 | 2004 | 22 | 0.060 |
Why?
|
| Protein Phosphatase 2 | 1 | 2005 | 90 | 0.060 |
Why?
|
| Hindlimb | 3 | 2009 | 111 | 0.060 |
Why?
|
| Cell Size | 1 | 2004 | 145 | 0.060 |
Why?
|
| GABA-B Receptor Antagonists | 1 | 2004 | 2 | 0.060 |
Why?
|
| Carbocyanines | 1 | 2004 | 38 | 0.060 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2004 | 36 | 0.060 |
Why?
|
| Disease Progression | 1 | 2015 | 6893 | 0.060 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2004 | 42 | 0.060 |
Why?
|
| Pro-Opiomelanocortin | 2 | 2017 | 110 | 0.060 |
Why?
|
| Receptors, Angiotensin | 1 | 2003 | 45 | 0.060 |
Why?
|
| Losartan | 1 | 2003 | 46 | 0.050 |
Why?
|
| Neural Conduction | 3 | 2002 | 113 | 0.050 |
Why?
|
| omega-N-Methylarginine | 1 | 2003 | 34 | 0.050 |
Why?
|
| Autoradiography | 1 | 2002 | 158 | 0.050 |
Why?
|
| Evoked Potentials | 1 | 2004 | 228 | 0.050 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 2003 | 47 | 0.050 |
Why?
|
| Reference Values | 3 | 2000 | 1153 | 0.050 |
Why?
|
| Prazosin | 1 | 2002 | 23 | 0.050 |
Why?
|
| Young Adult | 1 | 2021 | 22059 | 0.050 |
Why?
|
| Visceral Afferents | 1 | 2002 | 8 | 0.050 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2002 | 67 | 0.050 |
Why?
|
| Drinking | 1 | 2002 | 54 | 0.050 |
Why?
|
| Carboxypeptidases | 1 | 2002 | 25 | 0.050 |
Why?
|
| Glutamate Carboxypeptidase II | 1 | 2002 | 16 | 0.050 |
Why?
|
| Tibial Nerve | 1 | 2002 | 16 | 0.050 |
Why?
|
| Receptors, Opioid, kappa | 1 | 2002 | 33 | 0.050 |
Why?
|
| Dinoprostone | 2 | 2012 | 222 | 0.050 |
Why?
|
| Pregabalin | 1 | 2001 | 9 | 0.050 |
Why?
|
| Thiophenes | 1 | 2003 | 149 | 0.050 |
Why?
|
| Aspirin | 2 | 1995 | 390 | 0.050 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2003 | 151 | 0.050 |
Why?
|
| Instillation, Drug | 1 | 2001 | 15 | 0.050 |
Why?
|
| Hemicholinium 3 | 1 | 2001 | 5 | 0.050 |
Why?
|
| Purinergic P1 Receptor Antagonists | 1 | 2001 | 5 | 0.050 |
Why?
|
| Purinergic P1 Receptor Agonists | 1 | 2001 | 8 | 0.050 |
Why?
|
| Aziridines | 1 | 2001 | 20 | 0.050 |
Why?
|
| Binding Sites | 2 | 2003 | 2307 | 0.050 |
Why?
|
| Neurons, Efferent | 1 | 2001 | 8 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2002 | 278 | 0.050 |
Why?
|
| Stereoisomerism | 1 | 2001 | 178 | 0.050 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2004 | 532 | 0.050 |
Why?
|
| Endothelin-1 | 1 | 2001 | 63 | 0.050 |
Why?
|
| Injections, Intraperitoneal | 1 | 2001 | 209 | 0.050 |
Why?
|
| Celiac Artery | 1 | 2001 | 43 | 0.050 |
Why?
|
| Choline | 1 | 2001 | 75 | 0.050 |
Why?
|
| Mesenteric Arteries | 1 | 2001 | 66 | 0.050 |
Why?
|
| Vagotomy | 1 | 2000 | 26 | 0.050 |
Why?
|
| Stellate Ganglion | 1 | 2000 | 14 | 0.050 |
Why?
|
| Bone Neoplasms | 1 | 2014 | 2669 | 0.050 |
Why?
|
| Microscopy, Electron | 1 | 2002 | 735 | 0.050 |
Why?
|
| Microelectrodes | 1 | 2000 | 53 | 0.050 |
Why?
|
| Drug Administration Routes | 1 | 2000 | 63 | 0.050 |
Why?
|
| Amino Acids, Cyclic | 1 | 2000 | 1 | 0.050 |
Why?
|
| Lidocaine | 1 | 2000 | 79 | 0.050 |
Why?
|
| Vascular Resistance | 1 | 2001 | 215 | 0.050 |
Why?
|
| Endocardium | 1 | 2000 | 56 | 0.050 |
Why?
|
| Adolescent | 1 | 2021 | 32577 | 0.050 |
Why?
|
| Nitrites | 1 | 2000 | 68 | 0.040 |
Why?
|
| Bile Ducts | 2 | 1997 | 115 | 0.040 |
Why?
|
| Cyclooxygenase 1 | 1 | 2000 | 67 | 0.040 |
Why?
|
| Buffers | 1 | 1999 | 43 | 0.040 |
Why?
|
| Kinetics | 1 | 2003 | 2247 | 0.040 |
Why?
|
| Hypercapnia | 1 | 1999 | 28 | 0.040 |
Why?
|
| Adrenergic alpha-2 Receptor Agonists | 1 | 1999 | 33 | 0.040 |
Why?
|
| Acid-Base Equilibrium | 1 | 1999 | 66 | 0.040 |
Why?
|
| Electrodes | 1 | 1999 | 126 | 0.040 |
Why?
|
| Indans | 1 | 1999 | 70 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 641 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2012 | 547 | 0.040 |
Why?
|
| Thalamus | 1 | 2000 | 123 | 0.040 |
Why?
|
| Perforant Pathway | 1 | 2018 | 16 | 0.040 |
Why?
|
| Anions | 1 | 2018 | 37 | 0.040 |
Why?
|
| Exploratory Behavior | 1 | 1999 | 104 | 0.040 |
Why?
|
| Sympathectomy | 1 | 1998 | 16 | 0.040 |
Why?
|
| Parasympathomimetics | 1 | 1998 | 10 | 0.040 |
Why?
|
| Hydroxyl Radical | 2 | 1995 | 21 | 0.040 |
Why?
|
| Ion Transport | 1 | 2018 | 77 | 0.040 |
Why?
|
| Biological Transport, Active | 1 | 2018 | 135 | 0.040 |
Why?
|
| Myocardial Reperfusion | 2 | 1995 | 104 | 0.040 |
Why?
|
| Median Nerve | 1 | 1998 | 25 | 0.040 |
Why?
|
| Alkaloids | 2 | 2010 | 83 | 0.040 |
Why?
|
| Gyrus Cinguli | 1 | 2000 | 130 | 0.040 |
Why?
|
| Blood Gas Analysis | 2 | 1999 | 105 | 0.040 |
Why?
|
| Receptors, Histamine H1 | 1 | 1997 | 7 | 0.040 |
Why?
|
| Furans | 2 | 2010 | 103 | 0.040 |
Why?
|
| Histamine H1 Antagonists | 1 | 1997 | 25 | 0.040 |
Why?
|
| Dentate Gyrus | 1 | 2018 | 77 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2018 | 177 | 0.040 |
Why?
|
| Naphthalenes | 2 | 2010 | 84 | 0.040 |
Why?
|
| Sperm Motility | 1 | 2018 | 105 | 0.040 |
Why?
|
| Histamine | 1 | 1997 | 60 | 0.040 |
Why?
|
| Cyclooxygenase 2 | 1 | 2000 | 496 | 0.040 |
Why?
|
| Hydrogen Peroxide | 2 | 1995 | 225 | 0.040 |
Why?
|
| Adult | 2 | 2021 | 81555 | 0.040 |
Why?
|
| Agouti-Related Protein | 1 | 2017 | 51 | 0.040 |
Why?
|
| Software | 1 | 2004 | 1361 | 0.040 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 1 | 2017 | 54 | 0.040 |
Why?
|
| Models, Biological | 1 | 2006 | 3226 | 0.040 |
Why?
|
| Coronary Circulation | 2 | 1995 | 257 | 0.040 |
Why?
|
| Uterus | 1 | 2002 | 807 | 0.040 |
Why?
|
| China | 1 | 2018 | 642 | 0.030 |
Why?
|
| Pancreas | 2 | 1997 | 744 | 0.030 |
Why?
|
| Digestive System Physiological Phenomena | 1 | 1996 | 11 | 0.030 |
Why?
|
| Gastrointestinal Motility | 1 | 1997 | 88 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2000 | 1369 | 0.030 |
Why?
|
| Spermatozoa | 1 | 2018 | 324 | 0.030 |
Why?
|
| Mesentery | 1 | 1996 | 74 | 0.030 |
Why?
|
| Drug Combinations | 1 | 1998 | 634 | 0.030 |
Why?
|
| Naphthaleneacetic Acids | 1 | 1995 | 1 | 0.030 |
Why?
|
| Aminophylline | 1 | 1995 | 11 | 0.030 |
Why?
|
| Lipoxygenase | 1 | 1995 | 26 | 0.030 |
Why?
|
| Dipyridamole | 1 | 1995 | 41 | 0.030 |
Why?
|
| Neurokinin A | 1 | 1995 | 4 | 0.030 |
Why?
|
| Neurokinin-1 Receptor Antagonists | 1 | 1995 | 17 | 0.030 |
Why?
|
| Captopril | 1 | 1994 | 37 | 0.030 |
Why?
|
| Complement C5a | 1 | 1995 | 35 | 0.030 |
Why?
|
| Substance P | 1 | 1995 | 75 | 0.030 |
Why?
|
| Lymph | 1 | 1994 | 70 | 0.030 |
Why?
|
| Pinacidil | 1 | 2014 | 3 | 0.030 |
Why?
|
| Membrane Transport Modulators | 1 | 2014 | 9 | 0.030 |
Why?
|
| Acoustic Stimulation | 1 | 2014 | 118 | 0.030 |
Why?
|
| Pain, Postoperative | 1 | 2000 | 654 | 0.030 |
Why?
|
| 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine | 1 | 1993 | 1 | 0.030 |
Why?
|
| Testis | 1 | 2018 | 753 | 0.030 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2014 | 80 | 0.030 |
Why?
|
| Prostaglandin Antagonists | 1 | 1993 | 5 | 0.030 |
Why?
|
| Stiff-Person Syndrome | 1 | 2014 | 11 | 0.030 |
Why?
|
| Epoprostenol | 1 | 1994 | 86 | 0.030 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 1995 | 183 | 0.030 |
Why?
|
| Cholera Toxin | 1 | 2013 | 69 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2014 | 594 | 0.030 |
Why?
|
| Muscle Contraction | 1 | 1993 | 230 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2001 | 2123 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 3075 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2014 | 601 | 0.030 |
Why?
|
| Neutrophils | 2 | 1995 | 870 | 0.030 |
Why?
|
| Muscles | 1 | 1993 | 462 | 0.030 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2012 | 71 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2013 | 536 | 0.030 |
Why?
|
| Cell Survival | 1 | 2018 | 3081 | 0.030 |
Why?
|
| Myelin Sheath | 1 | 2013 | 171 | 0.030 |
Why?
|
| Quinolines | 1 | 1995 | 402 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 1011 | 0.020 |
Why?
|
| Parasympatholytics | 1 | 2010 | 12 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2012 | 665 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2011 | 404 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2014 | 791 | 0.020 |
Why?
|
| Idazoxan | 2 | 2000 | 4 | 0.020 |
Why?
|
| Freund's Adjuvant | 1 | 2009 | 50 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2014 | 993 | 0.020 |
Why?
|
| Endocannabinoids | 1 | 2009 | 26 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 1502 | 0.020 |
Why?
|
| Sodium | 2 | 2000 | 354 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2018 | 6027 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2013 | 1758 | 0.020 |
Why?
|
| Leucine | 2 | 2000 | 381 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2014 | 1192 | 0.020 |
Why?
|
| Sheep | 2 | 1999 | 276 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 1993 | 1011 | 0.020 |
Why?
|
| Epinephrine | 1 | 1989 | 249 | 0.020 |
Why?
|
| Potassium | 1 | 1989 | 349 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2009 | 593 | 0.020 |
Why?
|
| Rabbits | 1 | 1989 | 1089 | 0.020 |
Why?
|
| Liver | 1 | 1997 | 3126 | 0.020 |
Why?
|
| Biomarkers | 1 | 2018 | 5106 | 0.020 |
Why?
|
| Regional Blood Flow | 2 | 1999 | 286 | 0.020 |
Why?
|
| Mutation | 2 | 2018 | 15854 | 0.020 |
Why?
|
| Thiourea | 2 | 1995 | 20 | 0.020 |
Why?
|
| Peroxidase | 2 | 1995 | 134 | 0.010 |
Why?
|
| Superoxides | 2 | 1995 | 222 | 0.010 |
Why?
|
| Macrophages | 1 | 2010 | 1368 | 0.010 |
Why?
|
| Indoles | 1 | 2009 | 1035 | 0.010 |
Why?
|
| Carrageenan | 1 | 2003 | 16 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1995 | 4510 | 0.010 |
Why?
|
| Receptor, Endothelin A | 1 | 2001 | 18 | 0.010 |
Why?
|
| Dilatation | 1 | 2002 | 87 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 2002 | 162 | 0.010 |
Why?
|
| Endothelin Receptor Antagonists | 1 | 2001 | 26 | 0.010 |
Why?
|
| Electromyography | 1 | 2002 | 232 | 0.010 |
Why?
|
| Guanosine Triphosphate | 1 | 2001 | 106 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 2001 | 345 | 0.010 |
Why?
|
| Nomifensine | 1 | 2000 | 1 | 0.010 |
Why?
|
| omega-Conotoxins | 1 | 2000 | 7 | 0.010 |
Why?
|
| Desipramine | 1 | 2000 | 34 | 0.010 |
Why?
|
| Peptides, Cyclic | 1 | 2001 | 135 | 0.010 |
Why?
|
| Potassium Chloride | 1 | 2000 | 67 | 0.010 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 2000 | 32 | 0.010 |
Why?
|
| Cervix Uteri | 1 | 2002 | 252 | 0.010 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2000 | 46 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2000 | 339 | 0.010 |
Why?
|
| Pyrazoles | 1 | 2009 | 1542 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2003 | 1438 | 0.010 |
Why?
|
| Magnesium | 1 | 2000 | 173 | 0.010 |
Why?
|
| Swine | 2 | 1995 | 1610 | 0.010 |
Why?
|
| Sympatholytics | 1 | 1998 | 5 | 0.010 |
Why?
|
| Receptor, Bradykinin B2 | 1 | 1998 | 1 | 0.010 |
Why?
|
| Sympathomimetics | 1 | 1998 | 20 | 0.010 |
Why?
|
| Feedback | 1 | 2000 | 226 | 0.010 |
Why?
|
| Nicotinic Agonists | 1 | 1999 | 121 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 14864 | 0.010 |
Why?
|
| Chlorpheniramine | 1 | 1997 | 1 | 0.010 |
Why?
|
| Dimaprit | 1 | 1997 | 1 | 0.010 |
Why?
|
| Methylhistamines | 1 | 1997 | 2 | 0.010 |
Why?
|
| Pyrilamine | 1 | 1997 | 2 | 0.010 |
Why?
|
| Adrenergic Agents | 1 | 1997 | 21 | 0.010 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 1998 | 178 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2010 | 3928 | 0.010 |
Why?
|
| Arterial Occlusive Diseases | 1 | 1998 | 152 | 0.010 |
Why?
|
| Neurotransmitter Agents | 1 | 1997 | 174 | 0.010 |
Why?
|
| Partial Pressure | 1 | 1996 | 34 | 0.010 |
Why?
|
| Duodenum | 1 | 1997 | 170 | 0.010 |
Why?
|
| Amino Acids | 1 | 2000 | 787 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2011 | 4956 | 0.010 |
Why?
|
| Free Radical Scavengers | 1 | 1995 | 84 | 0.010 |
Why?
|
| Cell Aggregation | 1 | 1995 | 62 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2001 | 3542 | 0.010 |
Why?
|
| Transfection | 1 | 2000 | 3172 | 0.010 |
Why?
|
| 6-Ketoprostaglandin F1 alpha | 1 | 1994 | 12 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1995 | 161 | 0.010 |
Why?
|
| Diastole | 1 | 1995 | 189 | 0.010 |
Why?
|
| Sex Factors | 1 | 1999 | 2192 | 0.010 |
Why?
|
| Hydroxides | 1 | 1993 | 8 | 0.010 |
Why?
|
| Reperfusion | 1 | 1993 | 24 | 0.010 |
Why?
|
| Free Radicals | 1 | 1993 | 64 | 0.010 |
Why?
|
| Iron | 1 | 1995 | 379 | 0.010 |
Why?
|
| Oxygen | 1 | 1996 | 799 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1998 | 1934 | 0.010 |
Why?
|
| Ventricular Function, Left | 1 | 1995 | 580 | 0.010 |
Why?
|
| Algorithms | 1 | 1999 | 3910 | 0.000 |
Why?
|
| Cell Movement | 1 | 1993 | 2500 | 0.000 |
Why?
|
| Aged | 1 | 1989 | 73161 | 0.000 |
Why?
|
| Middle Aged | 1 | 1989 | 90021 | 0.000 |
Why?
|